Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | GFER | P55789 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28206083 | 0.78 | HTR2C (0.43) | CYP1A2NQO2NPC1RAB9AGFER | |
| SCHEMBL8344116 | 0.77 | CYP1A2 (0.54) | CYP1A2NQO2NPC1RAB9AALDH1A1 | |
| SCHEMBL29639029 | 0.77 | CYP1A2 (0.54) | CYP1A2NQO2NPC1RAB9AALDH1A1 | |
| SCHEMBL30578800 | 0.77 | CYP1A2 (0.54) | CYP1A2NQO2NPC1RAB9AALDH1A1 | |
| SCHEMBL21707839 | 0.74 | CYP1A2 (0.37) | CYP1A2HTR2CHTR2BPDE10A | |
| SCHEMBL22837059 | 0.74 | CYP1A2 (0.44) | CYP1A2KMT2AALDH1A1NPSR1PDE10A | |
| SCHEMBL22968487 | 0.72 | PDE10A (0.42) | CYP1A2KMT2AALDH1A1NPSR1GRM2 | |
| SCHEMBL21360900 | 0.71 | PDGFRB (0.39) | CYP1A2KMT2AMEN1NPC1RAB9A | |
| SCHEMBL6844954 | 0.70 | CYP1A2 (0.54) | CYP1A2NQO2NPC1RAB9AALDH1A1 | |
| SCHEMBL29639043 | 0.70 | CYP1A2 (0.54) | CYP1A2NQO2NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10964893-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-03-30 | — | — | US | disclosed |
| US-20180138419-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180138419-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, SLCO4C1 | CYP1A2 789/4885NQO2 1722/4885KMT2A 2934/4885 |
| US-10964893-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, SLCO4C1 | CYP1A2 789/4885NQO2 1722/4885KMT2A 2934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.